Spinraza (Nusinersen) Drug Interactions: What to Avoid and What to Tell Your Doctor

When you're taking a medication like Spinraza (nusinersen) — especially one as specialized as an intrathecal injection — it's natural to wonder how it might interact with other medications, supplements, and health conditions. The good news is that Spinraza has a relatively clean drug interaction profile compared to many other therapies. But there are important considerations that every patient and caregiver should understand.

This guide explains what is known about Spinraza drug interactions, which medications require special attention, and what to always tell your doctor.

The Good News: No CYP450 Drug-Drug Interactions

Many medications interact with each other because they are metabolized by the same set of liver enzymes — the cytochrome P450 (CYP450) system. When two drugs compete for the same enzymes, they can raise or lower each other's levels in dangerous ways.

Spinraza is not metabolized by the CYP450 enzyme system. Instead, it is broken down by exonuclease-mediated hydrolysis (enzymes that break down nucleic acid chains). This means Spinraza is unlikely to cause the typical drug-drug interactions associated with most pharmaceuticals. The prescribing information does not list any formal CYP450-mediated drug interactions.

Important Interaction #1: Anticoagulants and Antiplatelet Agents

Even though Spinraza doesn't interact with CYP450 enzymes, it does carry its own risk of thrombocytopenia (low platelet count) and coagulation abnormalities. This makes concurrent use of anticoagulants or antiplatelet medications a significant concern, as these drugs can compound Spinraza's effect on bleeding risk.

Medications that may increase bleeding risk when combined with Spinraza include:

Anticoagulants: warfarin (Coumadin), heparin, enoxaparin (Lovenox), rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa)

Antiplatelet agents: aspirin (at antiplatelet doses), clopidogrel (Plavix), ticagrelor (Brilinta)

NSAIDs at high doses: ibuprofen (Advil, Motrin), naproxen (Aleve), which have some antiplatelet activity at regular doses

Before each Spinraza dose, your doctor will check your platelet count and coagulation studies. If you're taking any blood-thinning or antiplatelet medications, always disclose this to your SMA specialist before your dose appointment. The team may recommend a temporary hold on blood-thinning medications around the time of the lumbar puncture.

Important Interaction #2: Nephrotoxic Medications and Kidney Function

Spinraza is eliminated primarily through the kidneys. Because it carries a risk of kidney toxicity (including glomerulonephritis), concurrent use of medications that are also nephrotoxic (toxic to the kidneys) or that are cleared by the kidneys could theoretically increase kidney-related risks.

Nephrotoxic medications to discuss with your doctor include:

Aminoglycoside antibiotics (gentamicin, tobramycin, amikacin) — commonly used in SMA patients for respiratory infections

NSAIDs (ibuprofen, naproxen) — especially with regular/chronic use

Contrast dye used in imaging studies — discuss timing with your doctor if you need a CT scan or MRI with contrast around your Spinraza dose date

Certain antiviral or antifungal medications with nephrotoxic potential

Concurrent SMA Therapies: What About Combining Spinraza with Other Treatments?

Concurrent use of Spinraza with other SMA disease-modifying therapies (risdiplam/Evrysdi, Zolgensma, Itvisma) is not a standard practice and is not supported by clinical evidence. Most insurance coverage policies explicitly exclude concurrent use of multiple SMA therapies. If you are considering switching therapies, work with your SMA specialist on an appropriate transition — which typically involves stopping one therapy before starting another.

Medications Commonly Used in SMA Patients: Safety Overview

SMA patients often take multiple medications for respiratory management, nutritional support, and orthopedic complications. Here's an overview of commonly used drug categories and their Spinraza interaction profile:

Respiratory medications (bronchodilators, inhaled steroids, mucolytics): No known direct interactions with Spinraza's mechanism; continue as prescribed.

Proton pump inhibitors / antacids: No known interaction with Spinraza.

Anesthetics and sedatives: Many Spinraza patients receive sedation or anesthesia for their injections. Discuss all current medications with the anesthesia team before each procedure.

Nutritional supplements: Fish oil and omega-3 supplements have mild antiplatelet effects. Disclose these to your doctor, especially at high doses.

Pregnancy and Breastfeeding Considerations

The safety of Spinraza during pregnancy is not established. No adverse effects on embryo-fetal development were observed in animal studies, but these data may not translate directly to humans. It is not known whether Spinraza passes into human breast milk (it has been detected in the milk of lactating mice). Always discuss pregnancy plans or breastfeeding with your SMA specialist before decisions are made.

What to Tell Your Doctor Before Each Spinraza Dose

Before every Spinraza injection, tell your healthcare provider about:

All prescription medications, including any recently started or stopped drugs

Over-the-counter drugs, especially aspirin, ibuprofen, or naproxen

Vitamins, supplements, and herbal products (especially fish oil, vitamin E, garlic, and ginkgo, which can affect platelet function)

Recent infections or illnesses, especially if treated with antibiotics

Pregnancy or breastfeeding

For more information on Spinraza's side effect profile, see: Spinraza Side Effects: What to Expect and When to Call Your Doctor.

Need help navigating access to Spinraza? medfinder is a paid service that helps patients find the right treatment resources for specialty medications.